跳至主要内容
临床试验/JPRN-jRCT1080220091
JPRN-jRCT1080220091未知4 期

A comparison of incidences of vertebral fracture in Japanese patients with osteoporosis treated with Etidronate and alfacalcidol; a randomized, double-blind study

Dainippon Sumitomo Pharma Co., Ltd.0 个研究点开始时间: 2005年9月12日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 <= 76age old(—)
性别
All

入选标准

  • -Primary osteoporosis
  • -Patient who had none or one to four vertebral (T4-L5) fracture(s)
  • -Menopausal or postmenopausal woman or man aged 50 to less than 77
  • -Patients who can walk (hospitalization/outpatient)
  • -Secondary osteoporosis
  • -Other diseases with reduced bone mass except secondary osteoporosis
  • -Radiographic finding that might affect the vertebral intensity

排除标准

  • 未提供

研究者

相似试验